Dexamethasone down-regulates ABCG2 expression levels in breast cancer cells

Biochemical and Biophysical Research Communications

Volumn 375, Issue 3, 2008, Pages 308-314

  Honorat, Mylène ^a,b,c   Mesnier, Aurélia ^a,b,c   Pietro, Attilio Di ^a   Lin, Valérie ^d   Cohen, Pascale ^a,b,c   Dumontet, Charles ^a,b,c   Payen, Léa ^a,b,c  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CENTRE LÉON BÉRARD   (France)

^d NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

ABC transporters; ABCG2; Breast cancer; Dexamethasone; Expression regulation; Multidrug resistance; Progesterone; Progesterone receptors

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE; MITOXANTRONE; PREGNANE X RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CELL; DOWN REGULATION; DRUG EFFICACY; DRUG SENSITIVITY; ENZYME ACTIVATION; GENETIC TRANSFECTION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

ANTINEOPLASTIC AGENTS, HORMONAL; ATP-BINDING CASSETTE TRANSPORTERS; BREAST NEOPLASMS; CELL LINE, TUMOR; DEXAMETHASONE; DOWN-REGULATION; HUMANS; MIFEPRISTONE; MITOXANTRONE; NEOPLASM PROTEINS; PROGESTERONE; RECEPTORS, GLUCOCORTICOID; RECEPTORS, STEROID; SUBSTRATE SPECIFICITY;

EID: 51049097901     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.07.149     Document Type: Article

References (21)

1. Robey R.W., Polgar O., Deeken J., To K.W., and Bates S.E. ABCG2: determining its relevance in clinical drug resistance. Cancer Metastasis Rev. 26 (2007) 39-57
2. Ee P.L., Kamalakaran S., Tonetti D., He X., Ross D.D., and Beck W.T. Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene. Cancer Res. 64 (2004) 1247-1251
3. Wang H., Lee E.W., Zhou L., Leung P.C., Ross D.D., Unadkat J.D., and Mao Q. Progesterone receptor (PR) isoforms PRA and PRB differentially regulate expression of the breast cancer resistance protein in human placental choriocarcinoma BeWo cells. Mol. Pharmacol. 73 (2008) 845-854
4. Leo J.C., Guo C., Woon C.T., Aw S.E., and Lin V.C. Glucocorticoid and mineralocorticoid cross-talk with progesterone receptor to induce focal adhesion and growth inhibition in breast cancer cells. Endocrinology 145 (2004) 1314-1321
5. Kastner P., Krust A., Turcotte B., Stropp U., Tora L., Gronemeyer H., and Chambon P. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 9 (1990) 1603-1614
6. Graham J.D., and Clarke C.L. Expression and transcriptional activity of progesterone receptor A and progesterone receptor B in mammalian cells. Breast Cancer Res. 4 (2002) 187-190
7. Bhadhprasit W., Sakuma T., Hatakeyama N., Fuwa M., Kitajima K., and Nemoto N. Involvement of glucocorticoid receptor and pregnane X receptor in the regulation of mouse CYP3A44 female-predominant expression by glucocorticoid hormone. Drug Metab. Dispos. 35 (2007) 1880-1885
8. Imai Y., Ishikawa E., Asada S., and Sugimoto Y. Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2. Cancer Res. 65 (2005) 596-604
9. H. Wang, L. Zhou, A. Gupta, R.R. Vethanayagam, Y. Zhang, J.D. Unadkat, Q. Mao, Regulation of BCRP/ABCG2 expression by progesterone and 17{beta}-estradiol in human placental BeWo cells, Am. J. Physiol. Endocrinol. Metab. 290 (2006) E798-E807 (First published December 13, 2005; doi:10.1152/ajpend0.00397.20050193-1849/06 $8.00).
10. Leo J.C., Wang S.M., Guo C.H., Aw S.E., Zhao Y., Li J.M., Hui K.M., and Lin V.C. Gene regulation profile reveals consistent anticancer properties of progesterone in hormone-independent breast cancer cells transfected with progesterone receptor. Int. J. Cancer 117 (2005) 561-568
11. Honorat M., Mesnier A., Vendrell J., Guitton J., Bieche I., Lidereau R., Kruh G.D., Dumontet C., Cohen P., and Payen L. ABCC11 expression is regulated by estrogen in MCF7 cells, correlated with estrogen receptor {alpha} expression in postmenopausal breast tumors and overexpressed in tamoxifen-resistant breast cancer cells. Endocr. Relat. Cancer 15 (2008) 125-138
12. Graidist P., Phongdara A., and Fujise K. Antiapoptotic protein partners fortilin and MCL1 independently protect cells from 5-fluorouracil-induced cytotoxicity. J. Biol. Chem. 279 (2004) 40868-40875
13. Ahmed-Belkacem A., Pozza A., Munoz-Martinez F., Bates S.E., Castanys S., Gamarro F., Di Pietro A., and Perez-Victoria J.M. Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2. Cancer Res. 65 (2005) 4852-4860
14. Dotzlaw H., Leygue E., Watson P., and Murphy L.C. The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue. Clin. Cancer Res. 5 (1999) 2103-2107
15. Moore J.T., and Kliewer S.A. Use of the nuclear receptor PXR to predict drug interactions. Toxicology 153 (2000) 1-10
16. Tsurufuji S., Sugio K., and Takemasa F. The role of glucocorticoid receptor and gene expression in the anti-inflammatory action of dexamethasone. Nature 280 (1979) 408-410
17. Pascussi J.M., Drocourt L., Fabre J.M., Maurel P., and Vilarem M.J. Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. Mol. Pharmacol. 58 (2000) 361-372
18. Meyer M.E., Pornon A., Ji J.W., Bocquel M.T., Chambon P., and Gronemeyer H. Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor. EMBO J. 9 (1990) 3923-3932
19. Gao X., and Nawaz Z. Progesterone receptors-animal models and cell signaling in breast cancer: role of steroid receptor coactivators and corepressors of progesterone receptors in breast cancer. Breast Cancer Res. 4 (2002) 182-186
20. Lonard D.M., and O'Malley B.W. Expanding functional diversity of the coactivators. Trends Biochem. Sci. 30 (2005) 126-132
21. Pavek P., Merino G., Wagenaar E., Bolscher E., Novotna M., Jonker J.W., and Schinkel A.H. Human breast cancer resistance protein: interactions with steroid drugs, hormones the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidine. J. Pharmacol. Exp. Ther. 312 (2005) 144-152